Drug Trial Radar · NCT06435429
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
Last checked: Nov 19, 2026Latest source record: Feb 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
550
Planned (sponsor's estimate)
Start
Aug 13, 2024
Primary completion
Apr 28, 2028
Study completion Oct 18, 2030
Sponsor
- Lead sponsor
- Jazz PharmaceuticalsJazz Pharmaceuticals (JAZZ)
- Sponsor type
- Industry
- First posted
- May 30, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The efficacy and safety of zanidatamab in combination with physician's choice of chemotherapy compared with trastuzumab in combination with physician's choice of chemotherapy will be evaluated for the treatment of participants with metastatic HER2-positive breast cancer who have progressed on, or are intolerant to, previous T-DXd treatment.
Conditions
- Metastatic HER2-positive Breast Cancer
Interventions
ZanidatamabDrug
Administered by intravenous infusion
TrastuzumabDrug
Administered by intravenous infusion
EribulinDrug
Administered by intravenous infusion
VinorelbineDrug
Administered by intravenous infusion
GemcitabineDrug
Administered by intravenous infusion
CapecitabineDrug
Given orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-free Survival (PFS) Per RECIST Version 1.1 As Assessed by Blinded Independent Central Review (BICR)Time frame: Until disease progression or death, up to approximately 44 months
Locations
166 sites in 15 countries. Site status is shown where the registry gives one.
Mayo Clinic Scottsdale - PPDS
Phoenix, Arizona · Recruiting
Arizona Oncology Tucson - Wilmot
Tucson, Arizona · Withdrawn
University of Arizona Cancer Center
Tucson, Arizona · Recruiting
The Oncology Institute Of Hope And Innovation
Cerritos, California · Recruiting
Los Angeles Hematology Oncology Medical Group Glendale
Glendale, California · Recruiting
USC-Norris Comprehensive Cancer Center - Investigational Drug Service IDS
Los Angeles, California · Recruiting
UCSF at Mission Bay MB
San Francisco, California · Recruiting
University of Colorado-Cancer Center-PPDS
Aurora, Colorado · Recruiting
Rocky Mountain Cancer Centers
Denver, Colorado · Recruiting
Medstar Georgetown University Hospital
Washington D.C., District of Columbia · Recruiting
Washington Cancer Center
Washington D.C., District of Columbia · Recruiting
Florida Cancer Specialists Research South
Fort Myers, Florida · Recruiting
Mayo Clinic Jacksonville - PPDS
Jacksonville, Florida · Recruiting
Florida Cancer Specialists Research North
St. Petersburg, Florida · Recruiting
Florida Cancer Specialists Research East
West Palm Beach, Florida · Recruiting
Dana Farber Cancer Institute
Boston, Massachusetts · Recruiting
Minnesota Oncology Hematology
Coon Rapids, Minnesota · Recruiting
Mayo Clinic - PPDS
Rochester, Minnesota · Recruiting
Saint Luke's Cancer Institute
Kansas City, Missouri · Recruiting
Hackensack Meridian Health
Hackensack, New Jersey · Recruiting
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey · Recruiting
Memorial Sloan Kettering
Long Island City, New York · Recruiting
Perlmutter Cancer Center 160 E 34th St
New York, New York · Recruiting
The Mount Sinai Hospital
New York, New York · Recruiting
Columbia University Medical Center 161 Fort Washington
New York, New York · Recruiting
Messino Cancer Center
Asheville, North Carolina · Recruiting
Duke Cancer Institute
Durham, North Carolina · Recruiting
UNC Central Investigational Drug Services
Morrisville, North Carolina · Recruiting
Oncology Hematology Care (OHC)
Cincinnati, Ohio · Recruiting
University Hospitals Cleveland Medical Center 11100 Euclid Ave
Cleveland, Ohio · Withdrawn
Abramson Cancer Center of The University of Pennsylvania
Philadelphia, Pennsylvania · Recruiting
Fox Chase Cancer Center
Philadelphia, Pennsylvania · Recruiting
Rhode Island Hospital
Providence, Rhode Island · Recruiting
Sarah Cannon Research Institute
Nashville, Tennessee · Recruiting
Texas Oncology - Fort Worth
Fort Worth, Texas · Recruiting
U.T. MD Anderson Cancer Center, Investigational Pharmacy Services
Houston, Texas · Recruiting
Millennium Research and Clinical Development
Houston, Texas · Withdrawn
Maryland Oncology Hematology Healing Way - USOR
Irving, Texas · Recruiting
Medical Oncology Hematology Consultants
Irving, Texas · Recruiting
Nexus Health
Irving, Texas · Recruiting
Showing 40 of 166 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.